<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04896268</url>
  </required_header>
  <id_info>
    <org_study_id>RADO study</org_study_id>
    <nct_id>NCT04896268</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of RAdiofrequency Versus HAL- RAR DOppler in Hemorrhoidal Pathology</brief_title>
  <acronym>RADO</acronym>
  <official_title>Prospective, Monocentric, Randomized, Open-label Study Comparing the Efficacy, in Terms of Quality of Life, and Safety of RAdiofrequency Versus HAL- RAR DOppler in Hemorrhoidal Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elsan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Elsan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Haemorrhoids are composed of tissue rich in blood vessels and are present in all individuals&#xD;
      inside the anus (internal haemorrhoids) or under the skin of the anus (external&#xD;
      haemorrhoids). Haemorrhoidal disease (HD) occurs when haemorrhoids become troublesome and&#xD;
      cause symptoms such as pain, bleeding, prolapse or oozing. In case of failure of medical&#xD;
      treatment, instrumental procedures or extensive disease, surgical treatment can be&#xD;
      considered. There are two classic surgical techniques. The first is the pedicle&#xD;
      haemorrhoidectomy of the Milligan and Morgan type. The second classic surgical technique is&#xD;
      the Longo stapled anopexy. Recently, less invasive surgical techniques such as arterial&#xD;
      ligation (HAL, with or without Doppler) followed by recto-anal repair (RAR for &quot;Recto Anal&#xD;
      Repair&quot;) and sometimes associated with mucopexy, which allows the excess mucosa to be ligated&#xD;
      and the muco-haemorrhoidal tissue to be fixed to the rectal wall, have developed. The use of&#xD;
      radiofrequency current (Rafaelo technique) in the treatment of haemorrhoidal disease is an&#xD;
      innovative technique of haemorrhoidal thermocoagulation. It is a mini-invasive technique,&#xD;
      which can be performed under sedation or short general anaesthesia (GA), with little pain,&#xD;
      allowing a rapid return to normal life and a short time off work. Although this technique is&#xD;
      already used in other European countries: Poland, Germany, Belgium, Great Britain (UK), there&#xD;
      is now a Polish, German, Spanish and English study in the process of publication. There have&#xD;
      been no studies in France to evaluate this new technique and assess its good tolerance, the&#xD;
      duration of work stoppage, the improvement in quality of life and the evaluation of its&#xD;
      effectiveness.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Interventional, prospective, therapeutic, comparative, parallel group, randomised controlled open-label, superiority, single-centre, national study.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To demonstrate an increase in quality of life, at 1 month post-procedure, when haemorrhoidal disease is managed with radiofrequency versus HAL-RAR with Doppler</measure>
    <time_frame>1-month visit</time_frame>
    <description>The Haemorrhoidal Disease and Anal Fissure questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain evaluation</measure>
    <time_frame>1-month visit</time_frame>
    <description>Numerical scale (minimum: 0; maximum: 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain evaluation</measure>
    <time_frame>6-month visit</time_frame>
    <description>Numerical scale (minimum: 0; maximum: 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>feasibility of the 2 techniques under simple antiplatelet agents, anti-vitamin K or oral anticoagulant.</measure>
    <time_frame>6-month visit</time_frame>
    <description>Success rate of radiofrequency procedure to be compared between patients taking or not taking AAP, AOD or VKA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of a relapse</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>date of relapse, if relapse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recording of specific symptoms that indicate improvement in hemorrhoidal disease</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Occurrence of bleeding / prolapse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to return to work</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Duration of work interruption (in days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety evaluation</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>Adverse event</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>Radiofrequency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rafaelo's technique consists of delivering a low temperature 4 MHz radiofrequency wave current into the haemorrhoidal vascular tissue using a large single-use needle with microfibre electrodes at the end. The intracellular water in the tissue and the injection of a locally injectable Xylocaine cushion serve as resistance to the vaporisation waves without releasing water vapour, thus avoiding the damage usually encountered in electrosurgery. The delayed phenomenon is cell volatilisation. Vaporisation of the tissue allows significant haemostasis without burns. Tissue changes will depend directly on the temperature emitted and the duration of exposure to the radiofrequence current. The fibrosis process starts during the session and continues for several days to weeks, allowing the reduction of the haemorrhoidal cushions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arterial ligation then recto-anal repair with Doppler</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arterial ligation aims to &quot;de-arterialise&quot; the haemorrhoids by selectively decreasing the arterial flow of the haemorrhoidal plexuses while avoiding obstructing the venous return. It is distinguished from mucopexy or recto anal repair (RAR®) which fixes the prolapsed hemorrhoidal plexus. Instead of excising the haemorrhoids, the principle is to reduce their size and to restore the anatomical relationships of the haemorrhoidal plexuses in the anal canal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiofrequency</intervention_name>
    <description>Rafaelo's technique consists of delivering a low-temperature 4 MHz radiofrequency wave current into the haemorrhoidal vascular tissue using a large single-use needle with microfibre electrodes at the end.</description>
    <arm_group_label>Radiofrequency</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arterial ligation then recto-anal repair with Doppler</intervention_name>
    <description>The aim of arterial ligation is to &quot;de-arterialise&quot; the haemorrhoids by reducing the arterial flow of the haemorrhoidal plexuses while avoiding obstructing the venous return.</description>
    <arm_group_label>Arterial ligation then recto-anal repair with Doppler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or Female consulting for hemorrhoidal pathology (grade II or III) after failure&#xD;
             of medico-instrumental treatments.&#xD;
&#xD;
          -  Age ≥ 18 years and &lt; 75 years&#xD;
&#xD;
          -  Mandatory affiliation to a health insurance system.&#xD;
&#xD;
          -  Patient having been informed of the study and having given informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic inflammatory bowel disease&#xD;
&#xD;
          -  Patients with suspected gastro-colic pathology&#xD;
&#xD;
          -  Haematological diseases&#xD;
&#xD;
          -  Anal fistulas&#xD;
&#xD;
          -  Patients unable to discontinue anti-vitamin K or oral anticoagulants&#xD;
&#xD;
          -  Associated anal fissure&#xD;
&#xD;
          -  External haemorrhoidal disease&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Patients under legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pflieger Hannah, MD</last_name>
    <phone>(0)2 48 68 85 63</phone>
    <phone_ext>+33</phone_ext>
    <email>docteurhannahpflieger@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Private hospital Guillaume de Varye</name>
      <address>
        <city>Saint-Doulchard</city>
        <zip>18230</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Pflieger Hannah, MD</last_name>
      <phone>(0)2 48 68 85 63</phone>
      <phone_ext>+33</phone_ext>
      <email>docteurhannahpflieger@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Aigner F, Bodner G, Gruber H, Conrad F, Fritsch H, Margreiter R, Bonatti H. The vascular nature of hemorrhoids. J Gastrointest Surg. 2006 Jul-Aug;10(7):1044-50.</citation>
    <PMID>16843876</PMID>
  </reference>
  <reference>
    <citation>Brown SR, Tiernan JP, Watson AJM, Biggs K, Shephard N, Wailoo AJ, Bradburn M, Alshreef A, Hind D; HubBLe Study team. Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial. Lancet. 2016 Jul 23;388(10042):356-364. doi: 10.1016/S0140-6736(16)30584-0. Epub 2016 May 25. Erratum in: Lancet. 2016 Jul 23;388(10042):342.</citation>
    <PMID>27236344</PMID>
  </reference>
  <reference>
    <citation>Loder PB, Kamm MA, Nicholls RJ, Phillips RK. Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg. 1994 Jul;81(7):946-54. Review.</citation>
    <PMID>7922085</PMID>
  </reference>
  <reference>
    <citation>Morgado PJ, Suárez JA, Gómez LG, Morgado PJ Jr. Histoclinical basis for a new classification of hemorrhoidal disease. Dis Colon Rectum. 1988 Jun;31(6):474-80.</citation>
    <PMID>3378471</PMID>
  </reference>
  <reference>
    <citation>Pigot F, Siproudhis L, Allaert FA. Risk factors associated with hemorrhoidal symptoms in specialized consultation. Gastroenterol Clin Biol. 2005 Dec;29(12):1270-4.</citation>
    <PMID>16518286</PMID>
  </reference>
  <reference>
    <citation>Riss S, Weiser FA, Schwameis K, Riss T, Mittlböck M, Steiner G, Stift A. The prevalence of hemorrhoids in adults. Int J Colorectal Dis. 2012 Feb;27(2):215-20. doi: 10.1007/s00384-011-1316-3. Epub 2011 Sep 20.</citation>
    <PMID>21932016</PMID>
  </reference>
  <reference>
    <citation>Simillis C, Thoukididou SN, Slesser AA, Rasheed S, Tan E, Tekkis PP. Systematic review and network meta-analysis comparing clinical outcomes and effectiveness of surgical treatments for haemorrhoids. Br J Surg. 2015 Dec;102(13):1603-18. doi: 10.1002/bjs.9913. Epub 2015 Sep 30. Review.</citation>
    <PMID>26420725</PMID>
  </reference>
  <reference>
    <citation>CRETON D. et le groupe closure®.Oblitération tronculaire saphène par le procédé radiofréquence VNUS Closure ®. résultats à 5 ans de l'étude multicentrique prospective,Phlébologie 2006,59 :67-72</citation>
  </reference>
  <reference>
    <citation>Becq A, Camus M, Rahmi G, de Parades V, Marteau P, Dray X. Emerging indications of endoscopic radiofrequency ablation. United European Gastroenterol J. 2015 Aug;3(4):313-24. doi: 10.1177/2050640615571159. Review.</citation>
    <PMID>26279839</PMID>
  </reference>
  <reference>
    <citation>VIVALDI.C,. TOLKSDORFS. SCHAFER H., Radiofrequency ablation of hemorroïds. First results of a new technique The Rafaelo Procedure.Endarmpraxis;Colorectal disease 2017, 19 (suppl 2) p.138</citation>
  </reference>
  <reference>
    <citation>BORD C., PILLANT H., FAVREAU-WELTZER C., SENEJOUX A., SOUDAN D., ARREDONDO BISONO T., ZKIK A., BERDEAU G., ABRAMOWITZ L. Development of A Validated Questionnaire Evaluating The Burden of The Haemorrhoidal Disease and Anal Fissure (Hemo-Fiss). Value in Health, VOLUME 18, ISSUE 7, PA630, NOVEMBER 01, 2015</citation>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 17, 2021</study_first_submitted>
  <study_first_submitted_qc>May 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

